Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model.
第一作者:
Mariangela,Garofalo
第一单位:
Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via F. Marzolo 5, 35131 Padova, Italy.
作者:
DOI
10.3390/pharmaceutics13040547
PMID
33919827
发布时间
2021-05-18
基金项目
CA 17140/This publication is based upon work from COST Action "Cancer Nanomedicine from the Bench to the Bedside" supported by COST (European Cooperation in Science and Technology)
GARO_SID19_02 (M.G.)/PRID-J funded by University of Padua
504/04496/1020/45.010406/Centre for Advanced Materials and Technologies, WUT, Poland and grant POB Biotechmed-1 (Excellence Initiative Research University)
SONATINA (2019/32/C/NZ7/00156) (L.K.)/Narodowe Centrum Nauki
1BWBW/19 (L.K.)/National Institute of Public Health-National Institute of Hygiene, Poland
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



